Barinthus Biotherapeutics plc (FRA:2AB)
Germany · Delayed Price · Currency is EUR 0.5950
+0.0100 (1.71%)
At close: Dec 19, 2025
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of €25.75 million as of December 22, 2025. Its market cap has decreased by -32.59% in one year.
Market Cap
25.75M
Enterprise Value
-27.68M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.60
Market Cap Chart
Since April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from 399.28M to 25.75M, a decrease of -93.55%. That is a compound annual growth rate of -44.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 25.75M | -45.14% |
| Dec 31, 2024 | 46.94M | -63.54% |
| Dec 29, 2023 | 128.74M | 56.98% |
| Dec 30, 2022 | 82.01M | -75.93% |
| Dec 31, 2021 | 340.74M | -14.66% |
| Apr 30, 2021 | 399.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.93B |
| Siemens Aktiengesellschaft | 183.57B |
| Allianz SE | 146.73B |
| Deutsche Telekom AG | 130.04B |
| Siemens Energy AG | 102.30B |
| Rheinmetall AG | 71.12B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 70.51B |
| Deutsche Bank Aktiengesellschaft | 62.30B |